+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

North America Exosome Diagnostic and Therapeutic Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Application; Product; End User, and Country

  • ID: 5028562
  • Report
  • April 2020
  • Region: North America
  • 82 pages
  • The Insight Partners
UP TO OFF
until Jan 15th 2021

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • AETHLON MEDICAL, INC
  • BIOREGENERATIVE SCIENCES
  • Cell Guidance Systems
  • Evomic Science LLC
  • EXOSOME DIAGNOSTICS
  • Miltenyi Biotec
  • MORE
The North American exosome diagnostic and therapeutic market is projected to reach US$ 1,54,116.95 thousand in 2027 from US$ 17,578.32 thousand; it is estimated to grow with a CAGR of 32.5% from 2020 to 2027.

The growth of the exosome diagnostic and therapeutic market is primarily attributed to greater precision and advantages over traditional methods of diagnosis and therapeutics and rise in R&D activities.

Higher benefits and advantages served by exosome biomarkers are enabling players to introduce advanced products. For instance, in January 2019, Avalon GloboCare Corp., one of the prime manufacturers of cell-based technologies, discovered a saliva-based exosomal biomarker - miR-185 - that can be used in oral cancer diagnosis and therapeutics. Moreover, the players involved in the exosome-aided diagnostics and treatment are introducing new technologies with intent to spread awareness and acceptance of the application of this method. For instance, in February 2019, NanoView Biosciences, Inc., a Boston-based biotechnology company, launched ExoView platform to enable the precise identification and characterization of exosomes. An increasing number of such R&D activities are accelerating the growth of the market.

In 2019, the diagnostics application segment accounted for a larger share of the North American exosome diagnostic and therapeutic market. Its growth is attributed to an increasing adoption of exosome-based instruments and kits for diagnosis of chronic conditions. Additionally, exosome-based diagnostic products offer benefits such as accuracy, lower processing time, and better ergonomics; these are likely to drive the growth of diagnostic application segment in the North American exosome diagnostic and therapeutic market.

In 2019, the instrument segment held a considerable share of the for exosome diagnostic and therapeutic market, by the product. This segment is also predicted to dominate the market by 2027 owing to higher demand for diagnostics instruments. However, the software segment is anticipated to witness growth at a significant rate during the forecast period.

A few major primary and secondary sources for the exosome diagnostic and therapeutic market included in the report are Instrument, US Food and Drug Administration, and Canada Foundation of Innovation.

Reasons to Buy
  • Save and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the North American exosome diagnostic and therapeutic market
  • Highlights key business priorities to assist companies in order to realign their business strategies
  • Highlights key findings and recommendations of crucial progressive industry trends in the North American exosome diagnostic and therapeutic market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinizes in-depth North American market trends and outlook coupled with the factors driving the market, as well as those hindering it
  • Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AETHLON MEDICAL, INC
  • BIOREGENERATIVE SCIENCES
  • Cell Guidance Systems
  • Evomic Science LLC
  • EXOSOME DIAGNOSTICS
  • Miltenyi Biotec
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 North America Exosome diagnostic and therapeutic Market - By Application
1.3.2 North America Exosome diagnostic and therapeutic Market - By Product
1.3.3 North America Exosome diagnostic and therapeutic Market - By End User
1.3.4 North America Exosome Diagnostic and Therapeutic Market - By Country

2. Exosome Diagnostic and Therapeutic Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Exosome Diagnostic and Therapeutic Market - Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 North America - PEST Analysis

5. North America Exosome Diagnostic and Therapeutic Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics
5.1.2 Rise in Research and Development Activities
5.2 Key Market Restraints
5.2.1 Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes
5.3 Key Market Opportunities
5.3.1 Growing Preference for Non-invasive and Novel Diagnostic Procedures
5.4 Future Trends
5.4.1 Automation of Exosome Isolation Process
5.5 Impact analysis

6. Exosome Diagnostic and Therapeutic Market- Regional Analysis
6.1 North America Exosome Diagnostic and Therapeutic Market Revenue Forecast and Analysis

7. Exosome Diagnostic and Therapeutic Market Analysis - By Application
7.1 Overview
7.2 Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
7.3 Diagnostic
7.3.1 Overview
7.3.2 Diagnostic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)
7.4 Therapeutic
7.4.1 Overview
7.4.2 Therapeutic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)

8. Exosome Diagnostic and Therapeutic Market Analysis - By Product
8.1 Overview
8.2 Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)
8.3 Instruments
8.3.1 Overview
8.3.2 Instruments: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
8.4 Reagents
8.4.1 Overview
8.4.2 Reagents: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
8.5 Software
8.5.1 Overview
8.5.2 Software: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)

9. Exosome Diagnostic and Therapeutic Market Analysis - By End User
9.1 Overview
9.2 Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)
9.3 Cancer Institutes
9.3.1 Overview
9.3.2 Cancer Institutes: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
9.5 Diagnostic Centres
9.5.1 Overview
9.5.2 Diagnostic Centres: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
9.6 Other End User
9.6.1 Overview
9.6.2 Other End Users: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)

10. Exosome Diagnostic and Therapeutic Market - Geographic Analysis
10.1 North America: Exosome Diagnostic and Therapeutic Market
10.1.1 Overview
10.1.2 North America: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.3 North America: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
10.1.4 North America: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.1.5 North America: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.1.6 North America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
10.1.7 US: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.7.1 US: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.7.2 US: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.1.7.3 US: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.1.7.4 US: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.1.8 Canada: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.8.1 Canada: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.8.2 Canada: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.1.8.3 Canada: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.1.8.4 Canada: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.1.9 Mexico: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.9.1 Mexico: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.9.2 Mexico: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.1.9.3 Mexico: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.1.9.4 Mexico: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)

11. Impact Of Covid-19 Pandemic On North America Exosome Diagnostic And Therapeutic Market
11.1 North America: Impact assessment of COVID-19 Pandemic

12. Exosome Diagnostic and Treatment Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies in The Exosome Diagnostic And Treatment Market, 2017-2020
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview

13. COMPANY PROFILES
13.1 Cell Guidance Systems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 BIOREGENERATIVE SCIENCES
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Evomic Science LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Norgen Biotek Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Miltenyi Biotec
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Therapeutic Solutions International, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 SWOT Analysis
13.6.5 Key Developments
13.7 AETHLON MEDICAL, INC
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 RENEURON GROUP PLC
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ITH, Immune Therapy Holdings AB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 EXOSOME DIAGNOSTICS
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Note: Product cover images may vary from those shown
  • AETHLON MEDICAL, INC
  • BIOREGENERATIVE SCIENCES
  • Cell Guidance Systems
  • Evomic Science LLC
  • EXOSOME DIAGNOSTICS
  • ITH, Immune Therapy Holdings AB
  • Miltenyi Biotec
  • Norgen Biotek Corp
  • RENEURON GROUP PLC
  • Therapeutic Solutions International, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll